Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial
- 16 June 2001
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 357 (9272), 1915-1924
- https://doi.org/10.1016/s0140-6736(00)05060-1
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery DiseaseThe New England Journal of Medicine, 2000
- Long-Term Treatment with a Platelet Glycoprotein-Receptor Antagonist after Percutaneous Coronary RevascularizationThe New England Journal of Medicine, 2000
- Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITEuropean Heart Journal, 2000
- Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trialEuropean Heart Journal, 1999
- Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trialJournal of the American College of Cardiology, 1999
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeThe Lancet, 1998
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 1998
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaThe New England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionThe New England Journal of Medicine, 1998
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJournal of the American College of Cardiology, 1988